[Form 4] HORACE MANN EDUCATORS CORP /DE/ Insider Trading Activity
Rhea-AI Filing Summary
Derik Tyson Sanders, Senior Vice President at Horace Mann Educators Corp (HMN), was granted 1,084 restricted stock units on 09/23/2025. The award is recorded as an acquisition at a $0 price and will vest on 09/23/2027, meaning the shares are not yet owned outright and will convert to common stock if and when vesting conditions are met. The Form 4 indicates no shares beneficially owned immediately following the transaction and the filing was signed on behalf of Mr. Sanders by an attorney-in-fact on 09/25/2025.
Positive
- Officer received 1,084 RSUs, aligning senior executive incentives with shareholder outcomes if vesting conditions are met
- Grant is time-based with a two-year vesting schedule (vests 09/23/2027), supporting retention
Negative
- None.
Insights
TL;DR Routine executive equity grant aligns officer incentives with shareholders but appears immaterial in size.
The reported 1,084 restricted stock units vesting in two years is a common form of long-term compensation for senior officers and supports alignment of executive incentives with shareholder value over time. The Form 4 shows the award was granted at no cash price and is unvested, which is consistent with compensation contingencies. There is no indication of accelerated vesting, related-party transactions, or immediate dilution effects in this filing. Impact on governance is standard and procedural.
TL;DR A time-based RSU grant was recorded; it appears to be routine compensation without immediate cash or ownership transfer.
The transaction code and explanation specify the grant is in the form of restricted stock units that vest on 09/23/2027. The reported price of $0 reflects a compensatory award rather than a market purchase. Because beneficial ownership following the transaction is reported as zero, the award remains unvested and will only affect share count and officer ownership upon vesting and conversion to common stock. No additional compensation details (target dollar value or grant rationale) are provided in the filing.